361 related articles for article (PubMed ID: 4463917)
1. [Cytostatic therapy of tumors of the lung].
De Marco F; Saviano G; Tenore G
Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
[No Abstract] [Full Text] [Related]
2. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
3. [Chemotherapy in advanced cancer of the lung].
Fleischer I; Wainstein R; Jovtis SL; Gibson AM; Barousse AP
Medicina (B Aires); 1979; 39(4):472-6. PubMed ID: 545078
[No Abstract] [Full Text] [Related]
4. Heparin and polychemotherapy for treatment of lung cancer.
Rohwedder JJ; Sagastume E
Cancer Treat Rep; 1977 Oct; 61(7):1399-401. PubMed ID: 589603
[No Abstract] [Full Text] [Related]
5. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
Perevodchikova NI; Bychkov MB
Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
[No Abstract] [Full Text] [Related]
6. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
[TBL] [Abstract][Full Text] [Related]
7. The role of chemotherapy in the treatment of lung cancer.
Selawry OS
Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
[No Abstract] [Full Text] [Related]
8. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR
Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
10. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
[TBL] [Abstract][Full Text] [Related]
11. Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
Elias EG
J Med; 1974; 5(1):114-32. PubMed ID: 4364885
[No Abstract] [Full Text] [Related]
12. Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer.
Pacilio G; Puzziello T
Bronches; 1971; 21(4):402. PubMed ID: 4340778
[No Abstract] [Full Text] [Related]
13. [After care in bronchial carcinoma. Results of postoperative polychemotherapy].
Karrer K; Pridun N; Denck H
Fortschr Med; 1976 Mar; 94(7):379-85. PubMed ID: 184021
[No Abstract] [Full Text] [Related]
14. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
Karrer K; Pridun N; Zwintz E
Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
[No Abstract] [Full Text] [Related]
15. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
Nüvemann M; Fernholz HJ; Frik W
Med Klin; 1976 Oct; 71(40):1676-83. PubMed ID: 184372
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lung.
Gottlieb JA; Serpick AA
Cancer Chemother Rep; 1970 Oct; 54(5):369-71. PubMed ID: 5514626
[No Abstract] [Full Text] [Related]
17. [Three years of experience in the polychemotherapy of inoperable bronchial carcinoma].
Wrbka E
Wien Med Wochenschr; 1974 Jul; 124(30):467-73. PubMed ID: 4139820
[No Abstract] [Full Text] [Related]
18. Chemotherapy of inoperable bronchogenic carcinoma.
Behera D; Malik SK
Indian J Chest Dis Allied Sci; 1985; 27(3):175-89. PubMed ID: 3017850
[No Abstract] [Full Text] [Related]
19. [Polychemotherapy of malignant tumors and hemoblastoses].
Kühböck J; Pokorny D; Steinbach K; Eggerth G
Wien Z Inn Med; 1968; 49(12):449-61. PubMed ID: 4311394
[No Abstract] [Full Text] [Related]
20. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
Bonadonna G; Tancini G; Bajetta E
Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
